Connect with us

Cannabis

The Largest Legal Batch of Cannabis Was Shipped from South Africa to the EU

On Wednesday, December 22nd, 2021, the Canadian company – which also grows outdoor cannabis on a large scale in South Africa, perhaps because of the sunnier climate there compared to its homeland in North America – sent out a press release to bring the mega shipment of medical cannabis to the attention of the media. The release was titled “Instadose Pharma Corp Ships 2,125 Metric Tons – Largest International Cannabis Delivery in History.”

Published

on

On December 25th, 2021, the largest batch of legal cannabis ever shipped arrived at its destination: North Macedonia. No less than 2,125 kilos of medicinal cannabis, with kind regards from South Africa on behalf of sender Instadose Pharma Corp.

If you want to find more details about the largest cannabis delivery from South Africa to the EU and to read other important cannabis news from around the world, download for free the Hemp.im mobile app.

‘Largest International Cannabis Delivery in History’

On Wednesday, December 22nd, 2021, the Canadian company – which also grows outdoor cannabis on a large scale in South Africa, perhaps because of the sunnier climate there compared to its homeland in North America – sent out a press release to bring the mega shipment of medical cannabis to the attention of the media.

Titled “Instadose Pharma Corp Ships 2,125 Metric Tons – Largest International Cannabis Delivery in History,” that message leaves nothing to the imagination. It is the largest batch of legal cannabis ever transported across the globe, in short.

Cannabis for North Macedonia and the EU

‘Changing the World of Cannabis.’ So reads the company slogan of the Canadians for a reason. The more than two million grams of cannabis were transported from Johannesburg to Skopje, where they were several thousand kilometers away – and it happened to be during Christmas.

Who will be happy about it anyway, is the European consumer, or rather medical cannabis patients in the European Union. ‘The product has already been sold and is destined for licensed pharmaceutical customers in the European Union,’ writes the company that specializes in quality outdoor cannabis. So pharmaceutical customers are cannabis patients, and they are those who buy their medicine in pharmacies on prescription from a doctor.

SEE ALSO  China's economic slowdown troubles German companies

Demand for medical cannabis high in THC

‘This is a historic shipment and it’s just the beginning of Instadose Pharma’s potential,’ explained the Canadians’ proud founder and boss Grant F. Sanders. ‘This delivery puts our business model on the map and makes our company a global leader in this industry. This has always been my vision.’

The special thing about Instadose’s cannabis is that it is budded cannabis with high levels of THC in it. This is apparently in high demand among European consumers. Or as Instadose puts it: ‘High levels of THC are in continual demand from pharmaceutical customers and Instadose Pharma will continue to grow and supply quality product to meet the market demand.’

This legal cannabis grower is already distributing medical cannabis through its platform in North America, Europe, Africa, Asia, and South America. It just goes to show how quickly legal cannabis has conquered the world – it’s a shame that the Netherlands is skipping this gold fleet so grandly.

__

(Featured image by dendoktoor via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in CNNBS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.